How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

524 results for

Saint Louis University Mental Status

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. Spatial displacement and diffusion of benefits among geographically focused policing initiatives Full Text available with Trip Pro

POLICING INITIATIVES Corresponding Author E-mail address: Jill Dando Institute of Crime Science, University College, London Corresponding author Kate Bowers Jill Dando Institute of Crime Science University College London. E-mail address: Jill Dando Institute of Crime Science, University College, London School of International and Public Affairs, Florida International University Jill Dando Institute of Crime Science, University College, London Jill Dando Institute of Crime Science, University College (...) , London Corresponding Author E-mail address: Jill Dando Institute of Crime Science, University College, London Corresponding author Kate Bowers Jill Dando Institute of Crime Science University College London. E-mail address: Jill Dando Institute of Crime Science, University College, London School of International and Public Affairs, Florida International University Jill Dando Institute of Crime Science, University College, London Jill Dando Institute of Crime Science, University College, London First

2011 Campbell Collaboration

162. Inhaled Nitric Oxide Therapy for Premature Infants

, and socioeconomic status were associated with increased benefit or risk from inhaled nitric oxide therapy. There is no information regarding effects of growth restriction, antenatal steroid use, multiple gestation, chorioamnionitis, or other antenatal factors. The Johns Hopkins University Evidence-based Practice Center systematic review reveals insufficient evidence of decreased incidence of death or bronchopulmonary dysplasia particular to any subgroup of premature infants treated with inhaled nitric oxide (...) Officer St. Louis Childrens Hospital St. Louis, Missouri Claudia Alleyne, M.D. Pediatric Neonatology Medical Director Neonatal Intensive Care Unit Kaiser Permanente Anaheim Medical Center Anaheim, California John D.E. Barks, M.D. Professor Department of Pediatrics and Communicable Diseases University of Michigan Medical School Director Division of Neonatal-Perinatal Medicine C.S. Mott Childrens Hospital University of Michigan Health System Ann Arbor, Michigan Robert J. Boyle, M.D., FAAP Professor

2010 NIH Consensus Statements

163. Diagnosis and Treatment of Degenerative Lumbar Spinal Stenosis (Revised 2011)

specialties have participated in the development and re- view of all NASS guidelines. To ensure broad-based representa- tion, NASS has invited and welcomes input from other societies and specialties Evidence Analysis Training of All NASS Guideline Developers NASS has initiated, in conjunction with the University of Al- berta’s Centre for Health Evidence, an online training program geared toward educating guideline developers about evidence analysis and guideline development. All participants in guide (...) 2005;30(8):936-943. 9. Atlas SJ, Tosteson TD, Hanscom B, et al. What is different about worker’s compensation patients? - Socioeconomic predictors of baseline disability status among patients with lumbar radicu- lopathy. Spine. Aug 2007;32(18):2019-2026. 10. Bederman SS, Kreder HJ, Weller I, Finkelstein JA, Ford MH, Y ee AJM. The who, what and when of surgery for the degenera- tive lumbar spine: a population-based study of surgeon factors, surgical procedures, recent trends and reoperation rates. Can

2011 North American Spine Society

164. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease Full Text available with Trip Pro

Modification: Recommendations. . . . . . . . . . . . . . . . .e395 4.4.1.1. Lipid Management. . . . . . . . . .e395 4.4.1.2. Blood Pressure Management. . .e397 4.4.1.3. Diabetes Management. . . . . . . .e398 4.4.1.4. Physical Activity. . . . . . . . . . . .e399 4.4.1.5. Weight Management. . . . . . . . .e400 4.4.1.6. Smoking Cessation Counseling. . . . . . . . . . . . . . . .e401 4.4.1.7. Management of Psychological Factors. . . . . . . .e401 4.4.1.8. Alcohol Consumption. . . . . . . .e402 4.4.1.9 (...) , the reader is referred to the “ACCF/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction” (STEMI). , Similarly, for patients with UA that is believed to be due to an acute change in clinical status attributable to an unstable plaque or an abrupt change in supply (eg, coronary occlusion with myocardial supply through collaterals), the reader is referred to the “ACCF/AHA Guidelines for the Management of Patients With Unstable Angina/non–ST-Elevation Myocardial Infarction

2011 American Heart Association

165. Diagnosis and Management of Hemochromatosis

, Development, and Evaluation; H63D, His63Asp mutation; HAMP, hepcidin; HCC, hepatocellular carcinoma; HH, hereditary hemochromatosis; HIC, hepatic iron concentration; HII, hepatic iron index; HJV, hemojuvelin; OLT, orthotopic liver transplantation; PCT, porphyria cutanea tarda; S65C, Ser65Cys mutation; TfR2, transferrin receptor-2; TS, transferrin saturation. From the 1 Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, Saint Louis, MO; 2 Department of Medicine (...) . Bacon, M.D., James F. King, M.D., Endowed Chair in Gastroenterology, Professor of Internal Medicine, Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, Saint Louis University Liver Center, 3635 Vista Avenue at Grand Boulevard, St. Louis, MO 63110-0250. E-mail: baconbr@slu.edu; fax: 314-577-8125. CopyrightV C 2011 by the American Association for the Study of Liver Diseases. View this article online at wileyonlinelibrary.com. DOI 10.1002/hep.24330 Potential con?ict

2011 American Association for the Study of Liver Diseases

166. Detrending Changes the Temporal Dynamics of a Semantic Fluency Task Full Text available with Trip Pro

Detrending Changes the Temporal Dynamics of a Semantic Fluency Task Objective: To study the dynamics of clustering semantic fluency responses and switching between clusters. Methods: We conducted a cross-sectional study of participants (N = 60) in a study of patient reported outcomes who were given the Saint Louis University Mental Status test. Sixty-second animal naming tests were scored for the timing of responses as well as the clustering of responses into semantic categories. Time scores

2016 Frontiers in aging neuroscience

167. Evaluating PROMIS(®) Applied Cognition Items In a Sample of Older Adults At Risk for Cognitive Decline Full Text available with Trip Pro

by an external rater, and compares PROMIS® Applied Cognition Abilities and Concerns subsets with commonly used "legacy" instruments. PROMIS® correlated with objective legacy measures (the Mini-Mental State Examination [MMSE] and Saint Louis University Mental Status [SLUMS] examination), depression (measured with the Geriatric Depression Scale [GDS]), anxiety, and activities of daily living. PROMIS® and MMSE correlations remained after controlling for depression and anxiety. PROMIS® associated more strongly (...) than MMSE with depression, highlighting the relationship between subjective cognitive deficit and depression. One-year changes in PROMIS® correlated with one-year changes in MMSE and GDS. The PROMIS® Abilities subset more strongly correlated with objective cognition, whereas the Concerns subset more strongly correlated with depression and activities of daily living. PROMIS® seems to be a reasonable prescreening tool to identify patients with cognitive decline or psychological distress.Copyright ©

2016 Psychiatry research

168. Detecting Change over Time: A Comparison of the SLUMS Exam and the MMSE in Older Adults At Risk for Cognitive Decline: Stability of the SLUMS Exam versus the MMSE Full Text available with Trip Pro

Detecting Change over Time: A Comparison of the SLUMS Exam and the MMSE in Older Adults At Risk for Cognitive Decline: Stability of the SLUMS Exam versus the MMSE To directly compare the 1-year stability of Mini-Mental State Examination (MMSE) score and Saint Louis University Mental Status (SLUMS) examination score and correlate score changes with demographic variables, clinical factors, and functional domains.A sample of 304 study participants was recruited from residential and clinical

2016 CNS neuroscience & therapeutics

169. F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected

314 362-1558 Locations Layout table for location information United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: John Doyle, BA, MA 314-747-1072 Sub-Investigator: Beau Ances, MD, PhD Sponsors and Collaborators Washington University School of Medicine Investigators Layout table for investigator information Principal Investigator: Tammie Benzinger, MD, PhD Washington University School of Medicine More Information Go (...) . F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03279523 Recruitment Status : Recruiting First Posted : September 12, 2017 Last Update

2016 Clinical Trials

170. Evaluating the Relationship Between Tau PET Imaging and CSF Biomarkers of AD (Alzheimer Disease) in Humans

research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03287765 Contacts Layout table for location contacts Contact: Kelley Jackson, BA 314 3621558 Contact: Theresa Butler, RN 314-362-1558 Locations Layout table for location information United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Kelley Jackson 314-362-1558 Sponsors (...) : NCT03287765 Recruitment Status : Recruiting First Posted : September 19, 2017 Last Update Posted : January 24, 2019 See Sponsor: Washington University School of Medicine Information provided by (Responsible Party): Washington University School of Medicine Study Details Study Description Go to Brief Summary: The purpose of this research study is to evaluate a new radioactive compound used in positron emission tomography (PET) scans in identifying tau tangles (a certain protein that might be associated

2016 Clinical Trials

171. Bariatric Embolization of Arteries for the Treatment of Nonalcoholic Steatohepatitis

: Keith Pereira, MD 314-268-5558 Locations Layout table for location information United States, Missouri Saint Louis University Saint Louis, Missouri, United States, 63110 Sponsors and Collaborators Keith Pereira, MD: Investigators Layout table for investigator information Principal Investigator: Keith Pereira, MD Assistant professor of radiology-Interventional radiology Principal Investigator: Brent Neuschwander-Tetri, MD Professor of medicine- gastroenterology Principal Investigator: Kirubahara (...) , 2016 Last Update Posted : August 17, 2018 See Sponsor: Keith Pereira, MD: Information provided by (Responsible Party): Keith Pereira, MD:, St. Louis University Study Details Study Description Go to Brief Summary: Obesity is an epidemic in the US. With progression of obesity, Nonalcoholic steatohepatitis (NASH) has been a growing public health issue. Presently there is no cure for NASH.Prevention of progression of fibrosis in NASH is crucial, as they are at a high risk for cirrhosis and may need

2016 Clinical Trials

172. A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis

Associates of Ormond Beach Completed Ormond Beach, Florida, United States, 32174 University of Florida Parkinson's Disease and Movement Disorder's Center Recruiting Tampa, Florida, United States, 33613 Contact: Robert Hauser, MD 813-396-0751 United States, Kansas University of Kansas Medical Center Recruiting Kansas City, Kansas, United States, 66160 Contact: Rajesh Pahwa, MD 913-588-6782 United States, Missouri Washington University School of Medicine Active, not recruiting Saint Louis, Missouri, United (...) on the neuropsychiatric inventory (NPI) Item A (delusions) and/or Item B (hallucinations).This criterion must be met at visits 1 and 3. 7. Subject has a Mini-mental status examination (MMSE) score > 16 points out of 30. 8. Subject has a caregiver (spouse or family member) who will be required to attend all visits and is able to provide study information on various scales such as the NPI and Zarit 22 scale. 9. Subject is taking antiparkinsonian drugs or deep brain stimulation, with a stable dose/dose regimen

2016 Clinical Trials

173. SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access

2 774 1611 Locations Layout table for location information Austria Medical University Vienna - General Hospital AKH Recruiting Vienna, Austria, 1090 Principal Investigator: Matthias Preusser, MD Belgium ZNA Middelheim Recruiting Antwerp, Belgium Principal Investigator: Dirk Schrijvers, MD Hopitaux Universitaires - Institut Jules Bordet Recruiting Brussels, Belgium, 1000 Principal Investigator: Thierry Berghmans, MD Cliniques Universitaires Saint-Luc Recruiting Brussels, Belgium, 1200 Principal (...) Investigator: Laurent Greillier, MD Centre d'Oncologie de Gentilly Recruiting Nancy, France, 54100 Principal Investigator: Dominique Spaeth Assistance Publique - Hopitaux de Paris - La Pitie Salpetriere Recruiting Paris, France, 75651 Principal Investigator: Laurence Leenhardt Principal Investigator: Marc Sanson Assitance Publique - Hopitaux de Paris - Hopital Saint-Louis Recruiting Paris, France Principal Investigator: Martine Bagot, MD Gustave Roussy Recruiting Villejuif, France Principal Investigator

2016 Clinical Trials

174. RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults

Atlanta Stockbridge, Georgia, United States, 30281 United States, Illinois Optimal Research Peoria, Illinois, United States, 61614 United States, Maryland Optimal Research Rockville, Maryland, United States, 20850 United States, Missouri Washington University in St. Louis, School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York United Medical Associates Binghamton, New York, United States, 13901 Regional Clinical Research Associates Endwell, New York, United States (...) in ≥ 55 Year Old Adults The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02873286 Recruitment Status : Completed First Posted : August 19, 2016 Last Update Posted : January 23, 2019 Sponsor: Bavarian Nordic Information provided by (Responsible Party): Bavarian Nordic Study Details Study Description Go

2016 Clinical Trials

175. SSRIs vs. TCAs for Depression in ALS Patients

and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT02851914 Recruitment Status : Recruiting First Posted : August 2, 2016 Last Update Posted : January 7, 2019 See Sponsor: St. Louis University Information provided by (Responsible Party (...) ): Ghazala Hayat, St. Louis University Study Details Study Description Go to Brief Summary: Depression is seen in 9-11% of ALS patients and adequate and proper treatment is needed. In this study, ALS patients will be screened for depression using self-reported multiple choice questionnaire. Patients who fulfill the criteria for depression based on this screening tool will be evaluated by psychiatrist before inclusion in the study. The investigators will also measure quality of life and functional status

2016 Clinical Trials

176. The Correlation of Women's Sexual Health and Marijuana Use

and Marijuana Use The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02865096 Recruitment Status : Completed First Posted : August 12, 2016 Last Update Posted : December 7, 2017 Sponsor: St. Louis University Information provided by (Responsible Party): Becky Lynn, MD, St. Louis University Study Details Study (...) by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02865096 Locations Layout table for location information United States, Missouri St. Mary's Health Center Saint Louis, Missouri, United States, 63117 Sponsors and Collaborators St. Louis University Investigators Layout table for investigator information Principal Investigator: Becky Lynn, MD St. Louis University More Information Go to Layout table for additonal information Responsible Party: Becky Lynn, MD, MD

2016 Clinical Trials

177. Reducing Readmissions in High-Risk Ostomates

to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02658123 Locations Layout table for location information United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Sponsors and Collaborators Washington University School of Medicine (...) and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02658123 Recruitment Status : Terminated (Decline in enrollment, lack of efficacy, and completion of funding accrual) First Posted : January 18, 2016 Last Update Posted : October 1, 2018 Sponsor: Washington University School of Medicine Information provided by (Responsible

2016 Clinical Trials

178. Bright Light on Fatigue in Women Being Treated for Breast Cancer

to this study by its ClinicalTrials.gov identifier (NCT number): NCT02658708 Locations Layout table for location information United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Sponsors and Collaborators Washington University School of Medicine Investigators Layout table for investigator information Principal Investigator: Horng-Shiuann Wu, Ph.D., R.N. Washington University School of Medicine More Information Go to Additional Information: Layout table (...) in Women Being Treated for Breast Cancer The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02658708 Recruitment Status : Completed First Posted : January 20, 2016 Last Update Posted : September 25, 2017 Sponsor: Washington University School of Medicine Information provided by (Responsible Party

2016 Clinical Trials

179. Cerclage for Short Cervix in Twins

is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02912390 Recruitment Status : Terminated (On Internal Hold) First Posted : September 23, 2016 Last Update Posted : April 13, 2018 Sponsor: St. Louis University Information provided by (Responsible Party): Laura Vricella, MD, St. Louis University Study Details Study Description Go to Brief Summary: Through cervical (...) of routine care at St. Mary's Health Center (SMHC) and Saint Louis University's (SLUCare) Physician Group. (Transvaginal cervical length measurement every 2 weeks from 16weeks/0days-23weeks/6days weeks, per hospital practice) Women pregnant with twin gestations at SMHC who meet study criteria will undergo transvaginal length screening between 16 and 24 weeks gestation. Those women with transvaginal cervical length measurements at or below 25 mm will be approached for study participation. If a patient

2016 Clinical Trials

180. Risk Reduction for Alzheimer's Disease

, Louisiana, United States, 70808 Contact: Sara Goff 225-763-0910 Principal Investigator: Jeffrey Keller, PhD United States, Missouri Washington University in St. Louis Recruiting Saint Louis, Missouri, United States, 63110 Contact: Monica Sewell 314-286-2716 Principal Investigator: Ellen Binder, MD United States, Texas UT Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Contact: Lauren Braunfeld, BS 214-345-7134 Contact: Ann Jacob, BSN 214-345-4665 Principal Investigator: Rong (...) of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT02913664 Recruitment Status : Recruiting First Posted : September 26, 2016 Last Update Posted : February 15, 2019 See Sponsor: University of Texas Southwestern Medical Center Collaborators: Texas Health Resources

2016 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>